Last updated 2026-07-26
- Raised $5M Seed round led by Tinguely International, Oct 2011
- Raised $166k grant, Feb 2024
- Raised $500k Series A, Jul 2019
Total raised
$5.7M
Last: Grant 2024-03
Stage
Seed
Founded
2010
Headcount
13
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
BioXtreme is an Israeli company developing robotics systems to assist in patient rehabilitation from strokes, traumatic brain injuries, and other neurological disorders. Their technology, including the deXtreme and Plaxtreme systems, integrates biofeedback and 3D virtual reality into real-life environments. BioXtreme's patented error augmentation technology amplifies movement errors to trigger the brain's natural adaptive responses, aiming to shorten rehabilitation time and improve motor skills.
Funding history · 4 rounds · $5.7M total
2024-02
Grant
$166K
2023-08
B Round
Undisclosed
★ ExitValley
2019-07
A Round
$500K
2011-10
Seed
$5.0M
★ Tinguely International★ Gefen Biomed Investments★ Office of the Chief Scientist
Headcount over time
From 2 (2018-08) to 17 (2026-03) · +15 (+750%) · 13 points · source: Finder history + radar grounding
Q&A
- What is BioXtreme's primary focus?
- BioXtreme is an Israeli company that develops robotics systems for neurorehabilitation, specifically to assist patients recovering from strokes, traumatic brain injuries, and other neurological disorders.
- What is BioXtreme's core technology?
- BioXtreme utilizes proprietary error augmentation technology, which amplifies movement errors to stimulate the brain's natural adaptive responses, aiming to accelerate motor recovery and shorten rehabilitation time.
- What products does BioXtreme offer?
- BioXtreme offers the deXtreme and Plaxtreme systems, which integrate biofeedback and 3D virtual reality into real-life environments to aid in rehabilitation.
- When was BioXtreme founded?
- BioXtreme was founded in April 2010.
- How many employees does BioXtreme currently have?
- BioXtreme has 11-50 employees.
- What was BioXtreme's most recent funding event?
- In March 2024, BioXtreme received a grant of $166,000 from the Israel Innovation Authority.
- What is the total amount of funding BioXtreme has raised to date?
- BioXtreme has raised a total of $15,000,000 USD.
- Does BioXtreme hold any patents?
- Yes, BioXtreme holds one patent.
Team · 1
Nini Bluman
Founder · Co-founder & CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingAugmented RealityArtificial IntelligenceMachinery & Robotics
Target customers
Financial ServicesFinancial ProductsInsuranceHealthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
neurologyimagingroboticsmedical-devicesrehabilitationaugmented-reality3d-technologystrokeartificial-intelligencedigital-healthcareinsurance-companieshealthcare-providersmedical-technologiesoptronicsdigital-therapeuticstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | bioxtremerobotics.com |
|---|---|
| linkedin.com/company/3138999 | |
| YouTube | youtube.com/channel/UCuD-eEZY3qwczScQObGaerw |
Identifiers & details
| Legal name | BioXtreme Ltd. |
|---|---|
| Founded | 2010-4 |
| Employees (exact) | 13 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | bioxtremerobotics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514435866 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2010-04-19 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — other (2), annual_report (2), shares_capital (1) |
| Registered address | התנופה 4 פתח תקווה |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-22 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-01-12 | דו~ח שנתי-הקצאת מניות |
| 2026-01-12 | דו~ח שנתי-עדכון בעלי מניות |
| 2026-02-03 | שינוי בתקנון |
| 2025-12-02 | הקצאת מניות |